BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 37506333)

  • 1. Pharmacogenomics Beyond Single Common Genetic Variants: The Way Forward.
    Lauschke VM; Zhou Y; Ingelman-Sundberg M
    Annu Rev Pharmacol Toxicol; 2024 Jan; 64():33-51. PubMed ID: 37506333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Personalized dosing from perspective of pharmacogenomics of drug metabolizing enzymes and transporters].
    Zhou Q; Yu LS; Zeng S
    Yao Xue Xue Bao; 2017 Jan; 52(1):1-7. PubMed ID: 29911367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomics: historical perspective and current status.
    Charlab R; Zhang L
    Methods Mol Biol; 2013; 1015():3-22. PubMed ID: 23824846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine.
    Ahmed S; Zhou Z; Zhou J; Chen SQ
    Genomics Proteomics Bioinformatics; 2016 Oct; 14(5):298-313. PubMed ID: 27729266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomics of drug-metabolizing enzymes and drug transporters in chemotherapy.
    Bosch TM
    Methods Mol Biol; 2008; 448():63-76. PubMed ID: 18370231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenomics: the inherited basis for interindividual differences in drug response.
    Evans WE; Johnson JA
    Annu Rev Genomics Hum Genet; 2001; 2():9-39. PubMed ID: 11701642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenomics: Driving Personalized Medicine.
    Sadee W; Wang D; Hartmann K; Toland AE
    Pharmacol Rev; 2023 Jul; 75(4):789-814. PubMed ID: 36927888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical trials in pharmacogenetics and pharmacogenomics: methods and applications.
    Rioux PP
    Am J Health Syst Pharm; 2000 May; 57(9):887-98; quiz 899-901. PubMed ID: 10840530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in pharmacogenetics and pharmacogenomics.
    Vesell ES
    J Clin Pharmacol; 2000 Sep; 40(9):930-8. PubMed ID: 10975065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenomics and Personalized Medicine.
    Cecchin E; Stocco G
    Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32580376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of pharmacogenetics of adverse drug reactions in elderly people.
    Cardelli M; Marchegiani F; Corsonello A; Lattanzio F; Provinciali M
    Drug Saf; 2012 Jan; 35 Suppl 1():3-20. PubMed ID: 23446782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenomics of adverse drug reactions: implementing personalized medicine.
    Wei CY; Lee MT; Chen YT
    Hum Mol Genet; 2012 Oct; 21(R1):R58-65. PubMed ID: 22907657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics and pharmacogenomics: recent developments, their clinical relevance and some ethical, social, and legal implications.
    Norbert PW; Roses AD
    J Mol Med (Berl); 2003 Mar; 81(3):135-40. PubMed ID: 12755119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomics for the forensic toxicologist.
    Kupiec TC; Raj V; Vu N
    J Anal Toxicol; 2006 Mar; 30(2):65-72. PubMed ID: 16620540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics and pharmacogenomics as tools in cancer therapy.
    Rodríguez-Vicente AE; Lumbreras E; Hernández JM; Martín M; Calles A; Otín CL; Algarra SM; Páez D; Taron M
    Drug Metab Pers Ther; 2016 Mar; 31(1):25-34. PubMed ID: 26863347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From pharmacogenetics to pharmaco-omics: Milestones and future directions.
    Auwerx C; Sadler MC; Reymond A; Kutalik Z
    HGG Adv; 2022 Apr; 3(2):100100. PubMed ID: 35373152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomics of phase II metabolizing enzymes and drug transporters: clinical implications.
    Yiannakopoulou ECh
    Pharmacogenomics J; 2013 Apr; 13(2):105-9. PubMed ID: 23044602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host genetic profiling to increase drug safety in colorectal cancer from discovery to implementation.
    Cecchin E; De Mattia E; Ecca F; Toffoli G
    Drug Resist Updat; 2018 Jul; 39():18-40. PubMed ID: 30075835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primer on medical genomics. Part XII: Pharmacogenomics--general principles with cancer as a model.
    Goetz MP; Ames MM; Weinshilboum RM
    Mayo Clin Proc; 2004 Mar; 79(3):376-84. PubMed ID: 15008610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges in current drug delivery from the potential application of pharmacogenomics and personalized medicine in clinical practice.
    Vizirianakis IS
    Curr Drug Deliv; 2004 Jan; 1(1):73-80. PubMed ID: 16305372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.